Utah Medical Products, Inc.UTMDNASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P33
Within normal range
vs 5Y Ago
-0.3x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -6.47% |
| Q3 2025 | -18.30% |
| Q2 2025 | 1.36% |
| Q1 2025 | 7.61% |
| Q4 2024 | -12.35% |
| Q3 2024 | -2.76% |
| Q2 2024 | -11.46% |
| Q1 2024 | -1.55% |
| Q4 2023 | -0.63% |
| Q3 2023 | -10.31% |
| Q2 2023 | -0.32% |
| Q1 2023 | -12.45% |
| Q4 2022 | -1.38% |
| Q3 2022 | 1.66% |
| Q2 2022 | 11.83% |
| Q1 2022 | -11.85% |
| Q4 2021 | 0.63% |
| Q3 2021 | 6.99% |
| Q2 2021 | 22.56% |
| Q1 2021 | -9.16% |
| Q4 2020 | 19.32% |
| Q3 2020 | 81.44% |
| Q2 2020 | -48.82% |
| Q1 2020 | -17.42% |
| Q4 2019 | 7.02% |
| Q3 2019 | -2.45% |
| Q2 2019 | 9.24% |
| Q1 2019 | -3.91% |
| Q4 2018 | -3.02% |
| Q3 2018 | -12.94% |
| Q2 2018 | 1.71% |
| Q1 2018 | 8.70% |
| Q4 2017 | -2.27% |
| Q3 2017 | -7.05% |
| Q2 2017 | 6.54% |
| Q1 2017 | 30.49% |
| Q4 2016 | -8.07% |
| Q3 2016 | -8.71% |
| Q2 2016 | 0.07% |
| Q1 2016 | 13.29% |